Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alocuro is an Australian regenerative medicine company specializing in advanced Platelet-Rich Plasma (PRP) technology and clinical application. The company provides the proprietary PRO-PRP system, a medical device designed to optimize the concentration of platelets and growth factors for autologous therapy. Beyond hardware, Alocuro offers comprehensive training and protocols for healthcare professionals to ensure standardized and effective treatment outcomes. Their clinical focus spans musculoskeletal medicine, orthopedics, and aesthetic procedures such as skin rejuvenation and hair loss treatment. By prioritizing high-purity PRP with minimal red blood cell contamination, Alocuro aims to enhance the body's natural healing response. The company operates primarily within the Australian and New Zealand markets, supporting a network of certified medical practitioners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alocuro.